Cell Therapy for Pulmonary Arterial Hypertension: Potential Efficacy of Endothelial Progenitor Cells and Mesenchymal Stem Cells Author:
Pulmonary arterial hypertension is a challenging disease, and our understanding of the underlying mechanisms and pathophysiology remains incomplete. However, there have been a number of important advances, which have greatly enriched our knowledge about the key mechanisms that contribute to the functional and pathological abnormalities of PAH. With each new wave of understanding come new opportunities for the rational design of therapies.